Ask any business leader what their primary business challenge is and you’ll often hear words like ‘demand’, ‘pipeline’ or ‘more, better leads’. There are very few businesses that can rely on a never-ending stream of inbound enquiries from prospects or customers looking to buy.
Generating demand is generally the domain of the marketing department, although in business-to-business environments it’s not uncommon for the sales people to be expected to find or develop about half of the demand themselves. Many businesses therefore take a well resourced, scientific and automated approach to being in the right places with the right content to engage those people looking to fix a problem or exploit an opportunity.
Despite what you might have read from the minority of practitioners who’ve written or published ‘how to’ books, blogs or videos on the subject, while the principles are straightforward the practice is hard, especially when the business has a relentless demand for high quantity, high quality expressions of interest to keep its costs of acquisition at manageable levels. What often happens is that instead of demand generation you get demand degeneration, by which I mean a lack or shortfall of pipeline for your products and services.
What are the reasons for this? As you might expect, they’re many and varied. Incorrect market sizing, poor segmentation, a lack of understanding of the customer, inferior or inappropriate content, and insufficient or manually dependent activities are some of the common reasons. There’s also a requirement to stay current with trends and technologies in demand generation, since ways of engaging with customers have a natural lifecycle that means they won’t always be productive and will be replaced by new ways.
It takes a relentless drive and relentless inquisitiveness to engender relentless interest in something. That’s a pretty tall order to avoid demand degeneration, and the good business will recognise this and have in place parallel activities like customer advocacy to keep the pump primed.